The EMulate Therapeutics Voyager® ulRFE® system is a non-invasive medical device. It is the first of many product expressions of the company’s underlying ulRFE platform technology. Showing promise in pre-clinical and clinical trials, the EMulate Therapeutics Voyager® has potential treatment applications in a wide range of diseases, including cancer, chronic pain, inflammatory, among others. The EMulate Therapeutics Voyager device is being evaluated for the treatment of glioblastoma multiforme (GBM) brain tumors in human clinical trials and is currently limited by Federal United States law to investigational use only.